comparemela.com

Latest Breaking News On - Synagis - Page 1 : comparemela.com

SYNAGIS (Palivizumab) for Respiratory Syncytial Virus (RSV) in 7MM: Market Size, Forecasts, and Emerging Insights 2019-2023 & 2023-2032

Dublin, April 30, 2024 (GLOBE NEWSWIRE) The "SYNAGIS Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about SYNAGIS for Respiratory syncytial virus (RSV) in the seven major markets. A detailed picture of the SYNAGIS for RSV in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019-2032 is provided in this report

United-kingdom
United-states
Germany
Japan
Dublin
Ireland
Italy
France
Spain
Clinical-development
Market-insight

vimarsana © 2020. All Rights Reserved.